Partial versus complete factor VIII inhibition in a mouse model of venous thrombosis.
暂无分享,去创建一个
A. Kauskot | P. Verhamme | M. Hoylaerts | M. Jacquemin | T. Vanassche | J. Emmerechts | S. Loyen | K. Cludts | C. Long | I. Van Linthout
[1] W. Ageno,et al. Single intravenous administration of TB‐402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose‐escalating, randomized, controlled trial , 2011, Journal of thrombosis and haemostasis : JTH.
[2] M. Makris,et al. The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies , 2011, International journal of laboratory hematology.
[3] B. Nemery,et al. Short‐term exposure to particulate matter induces arterial but not venous thrombosis in healthy mice , 2010, Journal of thrombosis and haemostasis : JTH.
[4] M. Poncz,et al. Towards a standardization of the murine tail bleeding model , 2010, Journal of thrombosis and haemostasis : JTH.
[5] T. Wakefield,et al. Thrombogenesis with continuous blood flow in the inferior vena cava , 2010, Thrombosis and Haemostasis.
[6] P. Verhamme,et al. Tolerability and pharmacokinetics of TB-402 in healthy male volunteers. , 2010, Clinical therapeutics.
[7] P. Verhamme,et al. A human monoclonal antibody inhibiting partially factor VIII activity reduces thrombus growth in baboons , 2009, Journal of thrombosis and haemostasis : JTH.
[8] B. Giraudeau,et al. Influence of source of phospholipids for APTT‐based factor IX assays and potential consequences for the diagnosis of mild haemophilia B , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.
[9] C. Legrand,et al. Hemostatic effects of recombinant DisBa-01, a disintegrin from Bothrops alternatus. , 2008, Frontiers in bioscience : a journal and virtual library.
[10] D. Quartermain,et al. Acute enoxaparin treatment widens the therapeutic window for tPA in a mouse model of embolic stroke , 2007, Neurological research.
[11] A. Girolami,et al. Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases , 2006, Journal of Thrombosis and Thrombolysis.
[12] R. Dwek,et al. Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibody , 2006, Journal of thrombosis and haemostasis : JTH.
[13] F. Rosendaal,et al. Mortality and causes of death in patients with hemophilia, 1992–2001: a prospective cohort study 1 , 2006, Journal of thrombosis and haemostasis : JTH.
[14] J. Hoogmartens,et al. Book Reviews : Who Expert Committee on Specifications for Pharmaceutical Preparations. Published by World Health Organisation, 1984. Price: Sw. fr. 6. Paperback. Pp 54. ISBN: 924 120704 3 , 1985, World Health Organization technical report series.
[15] M. Dewerchin,et al. Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice , 2004, Journal of thrombosis and haemostasis : JTH.
[16] K. Svenson,et al. Large-scale, high-throughput screening for coagulation and hematologic phenotypes in mice. , 2002, Physiological genomics.
[17] R. Bertina,et al. Elevated Factor VIII Levels and the Risk of Thrombosis , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[18] G. Broze,et al. A Tail Vein Bleeding Time Model and Delayed Bleeding in Hemophiliac Mice , 2001, Thrombosis and Haemostasis.
[19] M. Laffan,et al. Elevated plasma factor VIII levels--a novel risk factor for venous thromboembolism. , 2001, Clinical laboratory.
[20] J. Vermylen,et al. A New Animal Model of Thrombophilia Confirms that High Plasma Factor VIII Levels Are Thrombogenic , 1999, Thrombosis and Haemostasis.
[21] M F Hoylaerts,et al. Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor. , 1998, Blood.
[22] O. Ratnoff,et al. The changing prognosis of classic hemophilia (factor VIII "deficiency"). , 1991, Annals of internal medicine.
[23] D. Hoppensteadt,et al. Biochemical and Pharmacologic Inequivalence of Low Molecular Weight Heparins , 1989, Annals of the New York Academy of Sciences.